Switch to:
More From Other Websites
Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
Amgen, Celgene Buck Short Interest Trend In Biotech Stocks Feb 11 2016
19 Stocks You Should Own if the U.S. Falls Into a Recession Feb 11 2016
EU agency accepts Sandoz application for pegfilgrastim biosimilar Feb 11 2016
Novartis And the Future Of Drug Pricing Feb 10 2016
Relypsa: This Biotech Just Released Stunning Data Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
Major Biotech Short Interest Continues to Be Mixed Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
A new drug that could save the US billions of dollars just got one step closer to approval Feb 09 2016
Biotech ETFs Slide as Stocks Report Mixed Q4 Results Feb 09 2016
What Investors Can Expect from Healthcare Sector Companies Feb 09 2016
#1 Rated Biotech Analyst on the Sell-Off Feb 08 2016
3 Biotech Stocks to Turn the Tide This Earnings Season Feb 08 2016
Avoid biotech until elections? Analyst's view Feb 08 2016
Regeneron: It's the Eylea Outlook That Matters Feb 08 2016
UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's Feb 08 2016
UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's Feb 08 2016
UK cost agency rebuffs Sanofi cholesterol drug but backs Amgen's Feb 08 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK